InjectionCritical Care Injection Infusion

FAVIPIRAVIR

Favipiravir · RNA polymerase inhibitor antiviral

InjectionCritical Care Injection Infusion

FAVIPIRAVIRProspero Healthcare

Favipiravir is a RNA polymerase inhibitor antiviral supplied as tablets. It is used in standard clinical practice for influenza and mild to moderate viral respiratory infections, as described in general pharmacological references.

Uses

Influenza
Mild to moderate viral respiratory infections

Enquire about this product

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.

01Specification

Product details

Composition: Favipiravir
Available strengthsIndicative: 200 mg
Dosage form: Injection
Therapeutic category: Critical Care Injection Infusion
Therapeutic class: RNA polymerase inhibitor antiviral
Packing: Vial or ampoule, single unit or tray pack
Storage: Store below 25 °C, protected from light. Do not freeze.

02Related

From the same category

View the category